{"nct_id":"NCT01185821","title":"Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2018-02","start_date":"2010-08-30","start_date_type":"ACTUAL","primary_completion_date":"2016-10-10","primary_completion_date_type":"ACTUAL","completion_date":"2016-10-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}